Work

Abstract P6-20-07: Efficacy and safety of CB-839, a small molecule inhibitor of glutaminase, in combination with paclitaxel in patients with advanced triple negative breast cancer (TNBC): Initial findings from a multicenter, open-label phase 2 study

Year: 2019

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs18-p6-20-07

Authors: G Vidal, K Kalinsky, E Stringer-Reasor, F Lynce, J Cole, F Valdes-Albini, H Soliman, P Nikolinakos, A Silber, A DeMichele, H Ali, D Graham, J Giguere, A Brufsky, Y Liang, S Holland, G Fiji, B O'Keeffe, K Gogineni

Institutions: University of Miami, Henry Ford Hospital, Moffitt Cancer Center, University Cancer and Blood Center, Georgetown Lombardi Comprehensive Cancer Center, Columbia University

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2929070425

Cites:

Cited by: 16

Related to: 10